Cite
GLP-1RA therapy increases circulating vascular regenerative cell content in people living with type 2 diabetes.
MLA
Park, Brady, et al. “GLP-1RA Therapy Increases Circulating Vascular Regenerative Cell Content in People Living with Type 2 Diabetes.” American Journal of Physiology: Heart & Circulatory Physiology, vol. 327, no. 2, Aug. 2024, pp. H370–76. EBSCOhost, https://doi.org/10.1152/ajpheart.00257.2024.
APA
Park, B., Krishnaraj, A., Teoh, H., Bakbak, E., Dennis, F., Quan, A., Hess, D. A., & Verma, S. (2024). GLP-1RA therapy increases circulating vascular regenerative cell content in people living with type 2 diabetes. American Journal of Physiology: Heart & Circulatory Physiology, 327(2), H370–H376. https://doi.org/10.1152/ajpheart.00257.2024
Chicago
Park, Brady, Aishwarya Krishnaraj, Hwee Teoh, Ehab Bakbak, Fallon Dennis, Adrian Quan, David A. Hess, and Subodh Verma. 2024. “GLP-1RA Therapy Increases Circulating Vascular Regenerative Cell Content in People Living with Type 2 Diabetes.” American Journal of Physiology: Heart & Circulatory Physiology 327 (2): H370–76. doi:10.1152/ajpheart.00257.2024.